source
- Regenxbio reports successful Duchenne gene therapy trial, clearing path to FDA filingRegenxbio announced that its experimental gene therapy for Duchenne muscular dystrophy met its primary endpoints in a recent clinical trial, producing sufficient levels of a truncated muscle protei…
- Supreme Court blocks restrictions, keeps mifepristone available through pharmacies and mailSupreme Court on Thursday issued an order that maintains women's ability to obtain the abortion medication mifepristone without requiring an in-person doctor visit. The decision overturns a lower-…